Position in JNJ
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$1,041,277
+$34,185 QoQ
Shares Held
4,100
-0.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.79%
of 13F equity value
Holder Rank
#2,980
of 4,664 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Stone Summit Wealth LLC holds $13,570,520 across 6 Drug Manufacturers - General names. JNJ ranks #5 (7.7% of the industry book) .
All Filings in JNJ
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,041,277 | 4,100 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $1,007,092 | 4,120 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $866,085 | 4,185 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $777,836 | 4,195 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $559,065 | 3,660 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $606,974 | 3,660 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $561,993 | 3,886 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $640,947 | 3,955 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $578,062 | 3,955 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $662,499 | 4,188 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $709,091 | 4,524 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $708,506 | 4,549 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $773,971 | 4,676 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $724,780 | 4,676 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $854,102 | 4,835 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $263,009 | 1,610 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $293,424 | 1,653 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $285,340 | 1,610 | Shares | Sole | 2022-04-29 | |
| No filing history on record for this holder in this stock. | ||||||